Search for: "Pharmaceuticals USA, Inc." Results 1 - 20 of 916
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Apr 2019, 9:59 pm by Patent Docs
Teva Pharmaceuticals USA, Inc., the Federal Circuit reversed a decision by the U.S. [read post]
25 Nov 2015, 9:59 pm by Patent Docs
Teva Pharmaceuticals USA Inc., in a decision handed down earlier this month; the decision provides another example of the Court setting forth the contours of the scope of the... [read post]
14 Apr 2024, 9:19 pm by Patent Docs
Noonan -- In its recent decision in Janssen Pharmaceuticals, Inc. v. [read post]
29 Jul 2013, 9:26 pm by Patent Docs
This principle of patent law was reaffirmed by the Federal Circuit last week in Teva Pharmaceuticals USA, Inc. v. [read post]
23 Dec 2021, 8:48 pm by Patent Docs
One such decision arose earlier this month when the Federal Circuit affirmed a determination of non-obviousness by the Patent Trial and Appeal Board in an inter partes review proceeding, that opinion captioned Teva Pharmaceuticals USA, Inc. v. [read post]
10 Feb 2014, 7:01 pm by H. Scott Leviant
Teva Pharmaceuticals USA, Inc. was described as the end of the world by business interests when the Ninth Circuit held that attorneys could avoid CAFA removal by filing separate cases with fewer than 100 plaintiffs in each case to avoid the mass action provision in CAFA. [read post]
25 Jun 2017, 9:25 pm by Patent Docs
District Court for the District of Delaware issued a Memorandum Order that, inter alia, overruled objections by Defendants Glenmark Pharmaceuticals Inc., USA and Teva Pharmaceuticals USA, Inc. to a Report and Recommendation issued by Magistrate Judge Burke and adopted the Report. [read post]
13 Aug 2020, 9:59 pm by Patent Docs
Teva Pharmaceuticals USA, Inc., affirmed a District Court's finding that the asserted claims to a pharmaceutical formulation were indefinite. [read post]
17 May 2016, 8:30 pm by Patent Docs
Glenmark Pharmaceuticals Inc., USA the Federal Circuit demonstrated the resulting equipoise in affirming a district court's determination that the doctrine applied to an accused infringing generic formulation. [read post]
24 Feb 2022, 8:23 pm by Patent Docs
Teva Pharmaceuticals USA, Inc., the panel majority affirming a District Court decision that the claimed invention was indeed obvious. [read post]